Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Y Natkunam

Showing results (1-10 of 30) with videos related to

Pageof 3
Sort By:
The American Journal of Surgical Pathology|January 13, 2000
Utility of paraffin section immunohistochemistry for C-KIT (CD117) in the differential diagnosis of systemic mast cell disease involving the bone marrowY Natkunam, R V Rouse
Seminars in Diagnostic Pathology|April 12, 2001
Angiocentric lymphomas (lymphomatous vasculitis)Y Natkunam, R A Warnke
Archives of Pathology & Laboratory Medicine|March 7, 2001
Natural killer cell precursor acute lymphoma/leukemia presenting in an infantY Natkunam, A M Cherry, P J Cornbleet
Current Opinion in Immunology|February 1, 1993
Nuclear signaling by interleukin-6S Chen-Kiang, W Hsu, Y Natkunam, et al.
Transplant Infectious Disease : an Official Journal of the Transplantation Society|January 5, 2006
Treatment of verruca vulgaris with topical cidofovir in an immunocompromised patient: a case report and review of the literatureS Cha, L Johnston, Y Natkunam, et al.
Journal of Immunology (Baltimore, Md. : 1950)|October 15, 1994
Simultaneous activation of Ig and Oct-2 synthesis and reduction of surface MHC class II expression by IL-6Y Natkunam, X Zhang, Z Liu, et al.
American Journal of Clinical Pathology|May 7, 1999
Aggressive natural killer-like T-cell malignancy with leukemic presentation following solid organ transplantationY Natkunam, R A Warnke, J L Zehnder, et al.
Clinical Lymphoma|January 10, 2002
Durable remission in recurrent T-cell-rich B-cell lymphoma with the anti-CD20 antibody rituximabY Natkunam, T S Stanton, R A Warnke, et al.
Arthritis and Rheumatism|June 1, 1997
Epstein-Barr virus strain type and latent membrane protein 1 gene deletions in lymphomas in patients with rheumatic diseasesY Natkunam, K S Elenitoba-Johnson, D W Kingma, et al.
Cancer Genetics and Cytogenetics|September 22, 2001
A unique AML1 (CBF2A) rearrangement, t(1;21)(p32;q22), observed in a patient with acute myelomonocytic leukemiaA M Cherry, C D Bangs, P Jones, et al.
Pageof 3

Showing results (1-10 of 30) with videos related to

Sort By:
Pageof 3
The American Journal of Surgical Pathology|January 13, 2000
Utility of paraffin section immunohistochemistry for C-KIT (CD117) in the differential diagnosis of systemic mast cell disease involving the bone marrowY Natkunam, R V Rouse
Seminars in Diagnostic Pathology|April 12, 2001
Angiocentric lymphomas (lymphomatous vasculitis)Y Natkunam, R A Warnke
Archives of Pathology & Laboratory Medicine|March 7, 2001
Natural killer cell precursor acute lymphoma/leukemia presenting in an infantY Natkunam, A M Cherry, P J Cornbleet
Current Opinion in Immunology|February 1, 1993
Nuclear signaling by interleukin-6S Chen-Kiang, W Hsu, Y Natkunam, et al.
Transplant Infectious Disease : an Official Journal of the Transplantation Society|January 5, 2006
Treatment of verruca vulgaris with topical cidofovir in an immunocompromised patient: a case report and review of the literatureS Cha, L Johnston, Y Natkunam, et al.
Journal of Immunology (Baltimore, Md. : 1950)|October 15, 1994
Simultaneous activation of Ig and Oct-2 synthesis and reduction of surface MHC class II expression by IL-6Y Natkunam, X Zhang, Z Liu, et al.
American Journal of Clinical Pathology|May 7, 1999
Aggressive natural killer-like T-cell malignancy with leukemic presentation following solid organ transplantationY Natkunam, R A Warnke, J L Zehnder, et al.
Clinical Lymphoma|January 10, 2002
Durable remission in recurrent T-cell-rich B-cell lymphoma with the anti-CD20 antibody rituximabY Natkunam, T S Stanton, R A Warnke, et al.
Arthritis and Rheumatism|June 1, 1997
Epstein-Barr virus strain type and latent membrane protein 1 gene deletions in lymphomas in patients with rheumatic diseasesY Natkunam, K S Elenitoba-Johnson, D W Kingma, et al.
Cancer Genetics and Cytogenetics|September 22, 2001
A unique AML1 (CBF2A) rearrangement, t(1;21)(p32;q22), observed in a patient with acute myelomonocytic leukemiaA M Cherry, C D Bangs, P Jones, et al.
Pageof 3